Utah Medical Products, Inc. (NASDAQ:UTMD - Get Free Report) shares passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $56.88 and traded as high as $64.22. Utah Medical Products shares last traded at $63.30, with a volume of 5,331 shares traded.
Analysts Set New Price Targets
Separately, Weiss Ratings restated a "sell (d+)" rating on shares of Utah Medical Products in a research report on Saturday, September 27th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of "Sell".
Check Out Our Latest Report on Utah Medical Products
Utah Medical Products Stock Down 0.9%
The company has a market cap of $202.94 million, a PE ratio of 16.93 and a beta of 0.32. The firm has a 50 day simple moving average of $60.26 and a 200-day simple moving average of $56.88.
Utah Medical Products (NASDAQ:UTMD - Get Free Report) last issued its quarterly earnings results on Thursday, July 24th. The medical instruments supplier reported $0.94 earnings per share for the quarter. Utah Medical Products had a return on equity of 10.55% and a net margin of 32.34%.The business had revenue of $9.95 million for the quarter.
Utah Medical Products Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Thursday, October 2nd. Investors of record on Wednesday, September 17th were issued a dividend of $0.305 per share. The ex-dividend date of this dividend was Wednesday, September 17th. This represents a $1.22 dividend on an annualized basis and a dividend yield of 1.9%. Utah Medical Products's payout ratio is 32.62%.
Institutional Investors Weigh In On Utah Medical Products
A number of institutional investors and hedge funds have recently modified their holdings of the company. Brandes Investment Partners LP lifted its holdings in shares of Utah Medical Products by 12.0% during the second quarter. Brandes Investment Partners LP now owns 271,322 shares of the medical instruments supplier's stock worth $15,444,000 after purchasing an additional 29,073 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Utah Medical Products by 6.5% during the second quarter. Geode Capital Management LLC now owns 114,816 shares of the medical instruments supplier's stock worth $6,537,000 after purchasing an additional 7,040 shares during the period. Hotchkis & Wiley Capital Management LLC lifted its holdings in shares of Utah Medical Products by 35.2% during the first quarter. Hotchkis & Wiley Capital Management LLC now owns 101,640 shares of the medical instruments supplier's stock worth $5,696,000 after purchasing an additional 26,460 shares during the period. Minerva Advisors LLC lifted its holdings in shares of Utah Medical Products by 7.1% during the second quarter. Minerva Advisors LLC now owns 93,058 shares of the medical instruments supplier's stock worth $5,267,000 after purchasing an additional 6,156 shares during the period. Finally, Bank of New York Mellon Corp lifted its holdings in Utah Medical Products by 2.7% in the first quarter. Bank of New York Mellon Corp now owns 48,612 shares of the medical instruments supplier's stock valued at $2,724,000 after acquiring an additional 1,277 shares during the period. Institutional investors and hedge funds own 69.60% of the company's stock.
Utah Medical Products Company Profile
(
Get Free Report)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
